Suppr超能文献

凝固过程中固体纳米悬浮液的可成型性研究:II. 冷冻应力和冷冻保护剂性能的新作用

Study on formability of solid nanosuspensions during solidification: II novel roles of freezing stress and cryoprotectant property.

作者信息

Yue Peng-Fei, Li Gang, Dan Ji-Xiu, Wu Zhen-Feng, Wang Chang-Hong, Zhu Wei-Feng, Yang Ming

机构信息

Key Lab of Modern Preparation of TCM, Ministry of Education, Jiangxi University of Traditional Chinese Medicine, Nanchang, China.

Department of Pharmaceutics, 94th Hospital of People's Liberation Army, Nanchang, China.

出版信息

Int J Pharm. 2014 Nov 20;475(1-2):35-48. doi: 10.1016/j.ijpharm.2014.08.041. Epub 2014 Aug 23.

Abstract

The freezing stress and cryoprotectants were known to be the crucial factors for solidification formability of nanosuspensions during freeze-drying. However, there has been controversy as to whether an aggressive or conservative freezing stress (freezing temperature or freezing rate) prevents from irreversible aggregation of nanosuspensions. And the screening of cryoprotectants for solidification formability of nanosuspensions has largely relied on empirical approaches. A systematic investigation was presented herein regarding the effect of both the freezing stress and property of cryoprotectants on solidification formability of drug nanosuspensions during freeze-drying. It was found that at different freezing stresses (-20 °C, -80 °C, and -196 °C), the redispersibility of BCN, NGN, RCN, and RVL nanosuspensions stabilized, respectively, by seven stabilizers, was RDI(-20 °C)>RDI(-80 °C)>RDI(-196 °C). But the redispersibility of UDCA and OCA nanosuspensions stabilized, respectively, by seven stabilizers, was RDI(-20 °C)<RDI(-80 °C)<RDI(-196 °C). These phenomena could be explained by proposed novel crystal-stabilizer separation hypothesis in nano-concentrated phase during freezing, based on freezing rate, the diffusion characteristics of the drug crystals and stabilizer molecules. The two key properties of cryoprotectant that played an important role on the formability of nanosuspensions during freeze-drying were glass transition temperature and osmotic pressure. The cryoprotectant candidates with moderate π and Tg values, sucrose achieved the excellent solidification formability of drug nanosuspensions. And the firstly proposed classify guideline based on roles of freezing stress and cryoprotectant property could give a reference for process screening of solid nanosuspensions. This study will facilitate an in-depth understanding of formability of solid nanosuspensions during freeze-drying.

摘要

冷冻应力和冷冻保护剂被认为是冷冻干燥过程中纳米悬浮液固化成型性的关键因素。然而,对于采用激进还是保守的冷冻应力(冷冻温度或冷冻速率)来防止纳米悬浮液发生不可逆聚集,一直存在争议。而且,用于纳米悬浮液固化成型性的冷冻保护剂筛选在很大程度上依赖于经验方法。本文针对冷冻应力和冷冻保护剂性质对冷冻干燥过程中药物纳米悬浮液固化成型性的影响进行了系统研究。研究发现,在不同的冷冻应力(-20℃、-80℃和-196℃)下,分别由七种稳定剂稳定的BCN、NGN、RCN和RVL纳米悬浮液的再分散性为RDI(-20℃)>RDI(-80℃)>RDI(-196℃)。但分别由七种稳定剂稳定的UDCA和OCA纳米悬浮液的再分散性为RDI(-20℃)<RDI(-80℃)<RDI(-196℃)。基于冷冻速率、药物晶体和稳定剂分子的扩散特性,在冷冻过程中的纳米浓缩相中提出的新型晶体 - 稳定剂分离假说可以解释这些现象。冷冻保护剂的两个关键性质,即玻璃化转变温度和渗透压,在冷冻干燥过程中对纳米悬浮液的成型性起着重要作用。具有适度π值和Tg值的冷冻保护剂候选物蔗糖实现了药物纳米悬浮液优异的固化成型性。并且首次提出的基于冷冻应力和冷冻保护剂性质作用的分类指南可为固体纳米悬浮液的工艺筛选提供参考。本研究将有助于深入了解冷冻干燥过程中固体纳米悬浮液的成型性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验